Share-based Compensation Plans (Tables)

9 Months Ended

Sep. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Total share-based compensation recorded by the Company during the three and nine months ended September 30, 2016 and September 30, 2015 by line item is as follows:



	Three Months Ended September 30,						Nine Months Ended September 30,
(in millions)	2016			2015			2016			2015
Cost of sales	$	7.9		$	6.0		$	15.5		$	6.0
Research and development	14.4			9.4			33.4			21.0
Selling, general and administrative	24.9			4.6			49.1			28.5
Integration and acquisition costs	26.7			—			170.7			—
Reorganization costs	—			6.7			—			15.3
Total	73.9			26.7			268.7			70.8
Less tax	(26.9		)	(7.5		)	(73.2		)	(19.5		)
	$	47.0		$	19.2		$	195.5		$	51.3

Schedule of Replacement Awards

The following table presents additional information regarding the replacement options issued as of June 3, 2016:



(options and aggregate intrinsic values in thousands)	Options*	Weighted-average exercise price		Weighted-average contractual term (in years)	Aggregate intrinsic value
Issued and outstanding	13,290	$	43.12	7.69	$	242,467
Vested and exercisable	5,691	$	40.72	6.12	$	117,453
*Number of awards are stated in terms of ordinary share equivalents

Schedule of Share-based Payment Award, Valuation Assumptions

The weighted-average acquisition-date fair value and Black-Scholes assumptions related to replacement options issued to acquired Baxalta employees was as follows:



	As of June 3, 2016
Risk-free interest rate	1.20		%
Expected dividend yield	0.35		%
Expected life	3.9 years
Volatility	29.1		%
Fair value per Option*	$	79.31
*Pro rata portion of the fair value recognized as expense related to post combination service period

(number of RSUs in thousands)

Weighted average grant date fair value**

Issued and Outstanding

*Number of awards are stated in terms of ordinary share equivalents

**Reflects the pro rata portion representing future compensation as of June 3, 2016